Royal Bank of Canada »

Maplight Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $16k 474 34.70

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
FMR
Vanguard Capital Management
Blue Owl Capital Holdings
Paradigm Biocapital Advisors
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management

View all funds holding Maplight Therapeutics